Guanosine triphosphate (GTP) binding protein-coupled receptor proteins that bind histamine and are expressed in the brain
A full-length cDNA encoding a human-derived G protein-coupled receptor protein is isolated by screening a human hippocampus library. Also, a rat-derived cDNA corresponding to the human-derived cDNA is isolated. Proteins encoded by these cDNAs have an activity of lowering intracellular cAMP concentration under stimulation with histamine. These proteins are usable as tools in screening ligands thereof or in screening candidate compounds for drugs capable of regulating signal transduction from the above proteins.
1. A method for identifying a compound that modulates a histamine binding activity, the method comprising:
a) contacting (i) a polypeptide or (ii) a cell transfected with a nucleic acid encoding the polypeptide with a test compound, wherein the polypeptide comprises an amino acid sequence at least 95% identical to SEQ ID NO:20 or 25 and has a histamine binding activity; and
b) determining whether the test compound modulates the histamine binding activity of the polypeptide or cell,
thereby identifying a compound that modulates a histamine binding activity.
2. The method of claim 1 , wherein the method further comprises determining whether the test compound modulates cellular cAMP concentration, cellular calcium concentration, a G protein activation, phospholipase C activation, or intracellular pH.
3. The method of claim 1 , wherein the polypeptide comprises an amino acid sequence of a naturally occurring protein which binds to histamine.
4. The method of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:20.
5. The method of claim 1 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:25.
6. The method of claim 1 , wherein step a) comprises contacting the polypeptide with the test compound.
7. The method of claim 6 , wherein the polypeptide comprises an amino acid sequence of a naturally occurring protein which binds to histamine.
8. The method of claim 6 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:20.
9. The method of claim 6 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:25.
10. The method of claim 1 , wherein step a) comprises contacting the cell of (ii) with the test compound.
11. The method of claim 10 , wherein the polypeptide comprises an amino acid sequence of a naturally occurring protein which binds to histamine.
12. The method of claim 10 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:20.
13. The method of claim 10 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:25.
14. A method for identifying a compound that modulates a histamine binding activity, the method comprising:
a) contacting (i) a polypeptide or (ii) a cell transfected with a nucleic acid encoding the polypeptide with a test compound, wherein the polypeptide has a histamine binding activity and is encoded by a polynucleotide which hybridizes to a polynucleotide consisting of a complementary sequence of SEQ ID NO:21 or 26 under the conditions of 6×SSC, 40% formamide at 37° C., followed by a wash in 0.1×SSC containing 0.1% SDS at 62° C.; and
b) determining whether the test compound modulates the histamine binding activity of the polypeptide or cell,
thereby identifying a compound that modulates a histamine binding activity.
15. The method of claim 14 , wherein the method further comprises determining whether the test compound modulates cellular cAMP concentration, cellular calcium concentration, a G protein activation, phospholipase C activation, or intracellular pH.
16. The method of claim 14 , wherein the polypeptide comprises an amino acid sequence of a naturally occurring protein which binds to histamine.